Your browser doesn't support javascript.
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
Mori, Nobuaki; Katayama, Mitsuya; Nukaga, Shigenari.
  • Mori N; Department of General Internal Medicine and Infectious Diseases, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan. Electronic address: nobuaki.m@icloud.com.
  • Katayama M; Department of General Internal Medicine and Infectious Diseases, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan.
  • Nukaga S; Department of Respiratory Medicine, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan.
J Microbiol Immunol Infect ; 54(1): 109-112, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-813695

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pregnenediones / Azithromycin / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: J Microbiol Immunol Infect Journal subject: Allergy and Immunology / Microbiology Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pregnenediones / Azithromycin / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: J Microbiol Immunol Infect Journal subject: Allergy and Immunology / Microbiology Year: 2021 Document Type: Article